Investors

Investor information for NevoMD, a clinical reasoning and medical analysis platform developed by Nevonix.

NevoMD launched in Q1 2026 and is expanding its technology and operations worldwide.

NevoMD is currently privately funded and is looking to expand through strategic seed investment. If you represent a private or public seed investment firm and are interested in learning more, please contact us through our Contact form.